M3-Brigade Acquisition V Corp. (NASDAQ:MBAV – Get Free Report) saw a significant increase in short interest during the month of March. As of March 13th, there was short interest totaling 231,486 shares, an increase of 75.7% from the February 26th total of 131,764 shares. Currently, 0.6% of the shares of the company are sold short. Based on an average daily volume of 28,351 shares, the days-to-cover ratio is presently 8.2 days.
Wall Street Analysts Forecast Growth
Several brokerages recently weighed in on MBAV. Weiss Ratings restated a “sell (d-)” rating on shares of M3-Brigade Acquisition V in a research note on Monday, December 22nd. Wall Street Zen raised M3-Brigade Acquisition V to a “sell” rating in a research report on Saturday, March 14th. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock has an average rating of “Sell”.
View Our Latest Stock Analysis on MBAV
M3-Brigade Acquisition V Stock Up 0.1%
Institutional Trading of M3-Brigade Acquisition V
Hedge funds have recently modified their holdings of the company. Saba Capital Management L.P. acquired a new stake in shares of M3-Brigade Acquisition V during the 4th quarter worth approximately $151,000. Hudson Bay Capital Management LP acquired a new position in shares of M3-Brigade Acquisition V in the fourth quarter valued at $159,000. Prelude Capital Management LLC acquired a new position in shares of M3-Brigade Acquisition V in the third quarter valued at $281,000. Sandia Investment Management LP bought a new position in M3-Brigade Acquisition V in the second quarter worth $334,000. Finally, Clear Street LLC lifted its position in M3-Brigade Acquisition V by 2,280.8% in the second quarter. Clear Street LLC now owns 32,069 shares of the company’s stock worth $362,000 after purchasing an additional 30,722 shares during the period.
M3-Brigade Acquisition V Company Profile
M3-Brigade Acquisition V is a special purpose acquisition company (SPAC) sponsored by M3 Inc, a global healthcare information and technology provider, and Brigade Capital Management, an investment management firm. The company is structured as a blank‐check vehicle listed on the Nasdaq Stock Market under the ticker MBAV, with the objective of identifying and completing a business combination in the healthcare, life sciences or related sectors.
The company benefits from the operational expertise of M3’s digital health platform and real‐world data capabilities, combined with Brigade’s deep experience in credit and asset management.
Featured Stories
Receive News & Ratings for M3-Brigade Acquisition V Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for M3-Brigade Acquisition V and related companies with MarketBeat.com's FREE daily email newsletter.
